<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362221">
  <stage>Registered</stage>
  <submitdate>13/03/2012</submitdate>
  <approvaldate>15/03/2012</approvaldate>
  <actrnumber>ACTRN12612000296831</actrnumber>
  <trial_identification>
    <studytitle>Effect of 0.5% ketorolac tromethamine eye drop temperature on ocular comfort</studytitle>
    <scientifictitle>For healthy adults aged 18 to 45 years, will refrigeration of 0.5% ketorolac tromethamine eye drops, compared to room temperature ketorolac tromethamine eye drops, improve subjective ocular comfort?</scientifictitle>
    <utrn>U1111-1129-0614</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Ocular discomfort (stinging) during instillation of 0.5% ketorolac tromethamine eyedrops</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Normal eye development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>1 drop of refrigerated (at approximately 4 degrees Celsius) 0.5% ketorolac tromethamine will be administered in one eye of the subject.</interventions>
    <comparator>The wash-out period between treatments is one week. Thus, one week later, 1 drop of room temperature (approximately 22 degrees Celcius) 0.5% ketorolac tromethamine will be administered in the same eye of the subject.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Ocular comfort as assessed by the Ocular Surface Disease Index questionnaire</outcome>
      <timepoint>10 minutes after instillation of eyedrop</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Objective grading of ocular redness after instillation of eyedrop (Using the CCLRU Grading Scale)</outcome>
      <timepoint>15 minutes after instillation of eyedrop</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy adults aged 18-45 years</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>No ocular surface disease, no contact lens wearers</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/07/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of New South Wales</primarysponsorname>
    <primarysponsoraddress>UNSW
Anzac Parade
Kensington
2052 NSW</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of New South Wales</fundingname>
      <fundingaddress>Anzac Parade
Kensington 
2052 NSW</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Benjamin Ashby</sponsorname>
      <sponsoraddress>UNSW
Anzac Parade
Kensington 2052</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The use of topical ocular non-steroidal anti-inflammatory drugs (NSAIDs) has been limited by the common side effects of burning and stinging. It has been reported that lowering the temperature of lubricant eye drops results in improved ocular comfort. This research project is to determine if refrigeration of 0.5% ketorolac tromethamine prior to administration improves patient tolerability of the commercially available preparation. These findings may lead to an improved method of delivery that will reduce the adverse effect profile of topical NSAIDs, increase patient compliance and influence future prescribing trends.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>1/04/2012</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Katherine La</name>
      <address>UNSW
Anzac Parade
Kensington 2052</address>
      <phone>+61 2 9385 4639</phone>
      <fax />
      <email>katherinela@student.unsw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Katherine La</name>
      <address>UNSW
Anzac Parade
Kensington 2052</address>
      <phone>+61 2 9385 4639</phone>
      <fax />
      <email>katherinela@student.unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>